<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g339" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-336.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-331.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-331.html" >Cervical Cancer Screening for Women Who Attend STD Clinics or Have a History of STDs</a><span class="carrot"> > </span>
                    <a href="lv-336.html" >Special Considerations</a><span class="carrot"> > </span>Adolescents
            </div>
            </br><h3 class="sgc-1" id="sigil_toc_id_339">
 Adolescents
</h3>
<p>
 Prevalence of HR HPV is high among adolescents aged &lt;21 years (425). Infections in adolescent patients tend to clear rapidly, and lesions caused by these infections also have high rates of regression to normal. Therefore, ASCCP and ACOG recommend that adolescents with ASC-US or low-grade SIL be managed with repeat cytologic testing at 12 months and 24 months. Only those with HSIL at either follow-up visit or persistence of ASC-US or LSIL at 24 months should be referred for colposcopic evaluation.
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

